Oct
2026
Fiera Milano, Italy
Visit us
stand 20A9, Finished Dosage & Formulation
Aizant Drug Research Solutions Pvt. Ltd.
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:4
-
Employees:500 - 999
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 20A9, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Clinical Research Organization (CRO)
Capabilities:
• 2 Clinical Pharmacological Units with 164 beds • 14 LCMS-MS machines • AB-SCIEX 5500 • ICPMS Services:
• BA/BE Studies for Global Submissions • Patient PK studies • Clinical End Point Studies Volunteer Database:
• Male 14,000+ • Female 3,000+ Access to Post Menopausal Wom... -
Product Contract Formulation Development & Analytical Development (CDMO)
Contract Research and Development (Fee for Service)
Solids-
• Tablet, Capsule, PFOS, Granules, Sachets, Pellets • Oncology Potent and Veterinary products • MR,ER,SR,DR,GR,PR Dual Release • Mini-Tablet in Capsule, MUPS, Hot Melt Extrusion Injectables • Liquid, Lyoph... -
Product Contract Manufacturing Services (CMO)
Contract Manufacturing
(Oral Tablets and Capsules)
Capacity
Aizant’s advance manufacturing facilities are capable of handling 3 Billion units per annum (Tablets & Capsules, in both potent and general product manufacturing area)
Packaging Capabilities
qq... -
Product Out Licensing Dossiers
• Out Licensing • Technology Transfer • Co-Development / Profit Sharing with Technology Partners
API partners
Marketing Partners
&... -
Product Out Licensing Dossiers
• Out Licensing • Technology Transfer • Co-Development / Profit Sharing with •
Technology Partners
API partners
Marketing Partners
CMO Partners
